IBDEI0UT ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14180,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14180,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,14180,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,14181,0)
 ;;=E11.331^^82^774^19
 ;;^UTILITY(U,$J,358.3,14181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14181,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14181,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,14181,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,14182,0)
 ;;=E11.329^^82^774^16
 ;;^UTILITY(U,$J,358.3,14182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14182,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14182,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,14182,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,14183,0)
 ;;=E11.321^^82^774^17
 ;;^UTILITY(U,$J,358.3,14183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14183,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14183,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,14183,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,14184,0)
 ;;=E11.319^^82^774^24
 ;;^UTILITY(U,$J,358.3,14184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14184,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14184,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,14184,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,14185,0)
 ;;=E11.311^^82^774^25
 ;;^UTILITY(U,$J,358.3,14185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14185,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14185,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,14185,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,14186,0)
 ;;=E10.9^^82^774^13
 ;;^UTILITY(U,$J,358.3,14186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14186,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,14186,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,14186,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,14187,0)
 ;;=E10.311^^82^774^11
 ;;^UTILITY(U,$J,358.3,14187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14187,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14187,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,14187,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,14188,0)
 ;;=E10.319^^82^774^12
 ;;^UTILITY(U,$J,358.3,14188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14188,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14188,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,14188,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,14189,0)
 ;;=E10.36^^82^774^1
 ;;^UTILITY(U,$J,358.3,14189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14189,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,14189,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,14189,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,14190,0)
 ;;=E10.39^^82^774^2
 ;;^UTILITY(U,$J,358.3,14190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14190,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,14190,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,14190,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,14191,0)
 ;;=E10.321^^82^774^3
 ;;^UTILITY(U,$J,358.3,14191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14191,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14191,1,4,0)
 ;;=4^E10.321
 ;;^UTILITY(U,$J,358.3,14191,2)
 ;;=^5002594
 ;;^UTILITY(U,$J,358.3,14192,0)
 ;;=E10.329^^82^774^4
